emergency use featured image
News Pharmaceutical & Biotech Stories

Philippines Approves Pfizer-BioNTech Vaccine for Emergency Use

The Philippines has approved Pfizer-BioNTech’s COVID-19 vaccine, the first to be allowed for emergency use in the South-east Asia nation.

Thursday, January 14, the Philippines’ Food and Drug Administration said it had authorized the emergency use of the coronavirus vaccine from Pfizer Inc. and BioNTech SE.

The Pfizer-BioNTech vaccine has shown a 95 percent success rate, is the first vaccine the Philippines has approved and can be used for individuals aged 16 years old and up, said FDA Head Eric Domingo in a virtual briefing.

Pfizer vaccines may be among the first to arrive in the Philippines next month through the World Health Organisation-backed Covax facility, vaccine czar Carlito Galvez said

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS